Report overview
Nasal Drug Delivery is a route of administration in which drugs are insufflated through the nose. It can be a form of either topical administration or systemic administration, as the drugs thus locally delivered can go on to have either purely local or systemic effects. Nasal sprays are locally acting drugs such as decongestants for cold and allergy treatment, whose systemic effects are usually minimal.
This report aims to provide a comprehensive presentation of the global market for Nasal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Drug Delivery. This report contains market size and forecasts of Nasal Drug Delivery in global, including the following market information:
Global Nasal Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Nasal Drug Delivery market was valued at US$ 36830 million in 2022 and is projected to reach US$ 51740 million by 2029, at a CAGR of 5.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The nasal cavity is covered by a thin mucosa which is well vascularised. Therefore, a drug molecule can be transferred quickly across the single epithelial cell layer directly to the systemic blood circulation without first-pass hepatic and intestinal metabolism. The effect is often reached within 5 min for smaller drug molecules. Nasal administration can therefore be used as an alternative to oral administration, by crushing or grinding tablets or capsules and snorting or sniffing the resulting powder, providing a rapid onset of effects.
We surveyed the Nasal Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nasal Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Nasal Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Unit Dose
Multi-Dose
Metered Dose
Global Nasal Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Nasal Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Homecare
Global Nasal Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Nasal Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nasal Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nasal Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Sanofi-Aventis
Merck
AptarGroup
Johnson & Johnson Services
GlaxoSmithKline
Becton Dickson & Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nasal Drug Delivery, market overview.
Chapter 2: Global Nasal Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Nasal Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nasal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
